RFK Jr. said "everything is on the table" when it comes to how HHS will make America healthy again. Here are the top three things we are watching and discussing internally, including what's really required to make America healthy in the first place.
read full article ›Tariffs may seem like a distant economic lever, but in the biopharma industry, their effects could be immediate and far-reaching. From rising drug prices and potential shortages to widening health disparities, the downstream impact could touch every part of the healthcare system—and every patient it serves.
read full article ›We’re excited and honored that Fierce Healthcare named Real Endpoints financial assistance tool RE Assist as the Fierce Healthcare Innovation Award winner in the Financial/Operational Solutions category.
read full article ›Real Endpoints' was privileged to co-host the inaugural Cell Therapy Commercialization Leadership Forum along with Adjuvant Partners and Leavitt Partners with support from McKesson, FFF Enterprises and CIRM.
read full article ›We are so excited to announce that we have hired Shana Trexler as a Senior Account Executive to advance sales of RE Assist. A Fierce Healthcare Innovation winner in 2024, RE Assist is an innovative tool that supports people living with disease find financial support for their treatment costs.
read full article ›As expected, the U.S. Department of Health and Human Services announced the second round of drugs that will be subject to “negotiation” under the Inflation Reduction Act. It’s the last major healthcare move from the Biden Administration and a chance to keep the momentum going on its signature leglislation. Here is what we know – and what we don’t.
read full article ›Direct to consumer pharma models are a hot topic here at Real Endpoints. Roger Longman has thoughts. Let us know yours in the comments.
read full article ›Roger Longman isn't the only RE team member thinking deep thoughts about health care while in a beautiful place. Ellen Licking talks site of care optimization in this post. Add to the discussion in the comments.
read full article ›